Research, Portfolio Monitoring, Investment Tools, and More.

MarketBeat All Access is the premier all-in-one stock research solution that helps you identify the best stocks, monitor your portfolio, and keep track of the market. You get our top stock ideas, best-in-class research tools, real-time alerts, proprietary research reports, and much more.

Start Your Free Trial Today

Free For 30 Days. Then, $249.00/year.

a couple facing laptop and staring at it
Start Your 30-Day Free Trial

Your Success is Our Success Take The Guesswork out of Investing

We believe that successful investing shouldn't be complicated, which is why MarketBeat All Access simplifies stock selection for our members by regularly providing new ideas and insights.

As a subscriber, you'll immediately receive our top stock ideas enabling you to spend less time navigating the complexities of the market and more time doing what you love.

Start Your 30-Day Free Trial
MarketBeat All Access on desktop and phone devices

Stock Ideas from The Idea Engine™

MGA Magna International

down 11.19% 90 days after 2/19/2026

The MarketBeat Idea Engine™ identified Magna International as having momentum on 2/19/2026. An alert was sent out to MarketBeat subscribers at approximately 9:00 AM EST. The stock was trading at $66.80 at the time of the recommendation. After 90 days, the stock was trading at $59.33, representing a -11.19% ROI. The current price for MGA is $64.58.

EXC Exelon

down 10.52% 90 days after 2/16/2026

The MarketBeat Idea Engine™ identified Exelon as having a strong positive sentiment on 2/16/2026. An alert was sent out to MarketBeat subscribers at approximately 9:00 AM EST. The stock was trading at $48.48 at the time of the recommendation. After 90 days, the stock was trading at $43.38, representing a -10.52% ROI. The current price for EXC is $46.23.

HLT Hilton Worldwide

up 0.46% 90 days after 2/16/2026

The MarketBeat Idea Engine™ identified Hilton Worldwide as having a strong positive sentiment on 2/16/2026. An alert was sent out to MarketBeat subscribers at approximately 9:00 AM EST. The stock was trading at $314.62 at the time of the recommendation. After 90 days, the stock was trading at $316.05, representing a 0.46% ROI. The current price for HLT is $321.34.

HOG Harley-Davidson

up 23.85% 90 days after 2/16/2026

The MarketBeat Idea Engine™ identified Harley-Davidson as having a strong negative sentiment on 2/16/2026. An alert was sent out to MarketBeat subscribers at approximately 9:00 AM EST. The stock was trading at $20.42 at the time of the recommendation. After 90 days, the stock was trading at $25.29, representing a 23.85% ROI. The current price for HOG is $23.79.

ICHR Ichor

up 56.66% 90 days after 2/16/2026

The MarketBeat Idea Engine™ identified Ichor as having momentum on 2/16/2026. An alert was sent out to MarketBeat subscribers at approximately 9:00 AM EST. The stock was trading at $46.77 at the time of the recommendation. After 90 days, the stock was trading at $73.27, representing a 56.66% ROI. The current price for ICHR is $68.96.

Free Trial Offer You are only one step away from gaining access to world-class investing tools and research.

Get Your 30-Day Free Trial of MarketBeat All Access Today!

Annual Billing

$249.00/year
Save $99.00 with annual billing!
Get All Access with Annual Billing

Monthly Billing

$29.00/month
Get All Access with Monthly Billing
30-Day Money Back Guarantee

Experience MarketBeat All Access Risk-Free with Our 30-Day Free Trial

We're confident you'll discover the immense value of MarketBeat All Access during your free 30-day trial that we offer it with no strings attached. If you decide to cancel within the first 30 days, you can do so online with no questions asked.

Try it out – you have nothing to lose.
Feature
Daily Ratings
Free
All Access
$249/yr or $29/mo

Daily Financial News

Top News Headlines
Premium Articles
Weekly Market Preview Delivered every Sunday, MarketBeat's weekly market preview provides an executive briefing on the most important market events and stories that will be in the news in the coming week.
Real-Time News Feed
Newsletter Delivery Time 1:30 PM ET 8:50 AM ET & 4:30 PM ET

Market Data

Analysts' Upgrades and Downgrades
Congressional Trading
Dividend Announcements
Earnings Calls and Results
FDA Calendar
Insider Buying and Selling
Institutional Buying and Selling

Portfolio Monitoring

My MarketBeat Portfolio Monitoring Tool
My MarketBeat Watchlist Size Up to 10 stocks Unlimited
Personalized News for Your Stocks Receive a personalized A.I. generated summary of the news and market events that are most likely to impact your stock portfolio. Up to 10 stocks Unlimited
Email & SMS News Alerts Receive an email or SMS alert whenever one of your stocks receives a ratings change, announces a dividend, announces earnings, has insider trading activity or has other important news. Up to 10 stocks
Follow Analysts
Follow Brokerages
Brokerage Linking Create a watchlist securely linked to your brokerage account for automatic updates whenever you buy or sell stock.

Stock Screeners

Stock Screener
Dividend Screener
Earnings Screener
ETF Screener
Insider Trades Screener
Ratings Screener
Premium Filters (news sentiment, MarketRank, consensus) Filter stocks on screener pages by news sentiment, MarketRank, and Wall Street analysts' consensus.

Web-Based Research Tools

Calculators
Compare Stocks
Idea Engine™
Momentum Alerts
Excel/CSV Data Export Export up to 6 months of analyst recommendations, dividend announcements, earnings announcements and insider trades for your own analysis.

Trending Stocks

Trending Stocks on MarketBeat
Media Sentiment Stocks
Media Sentiment Analysis See which stocks are receiving the most positive news coverage right now.

Company Profile Pages

Analyst Recommendations View all recommendations issued for a stock in the last two years.
Consensus Ratings and Targets View current consensus analyst recommendations and price targets for any stock.
Dividend History View the most recent five years of dividend payments and key metrics dividend investors use to rate dividend-paying stocks.
Earnings History and Estimates View historical earnings information and earnings estimates for upcoming quarters.
FDA Events Track FDA approvals, PDUFA dates, clinical trial outcomes, and other regulatory milestones for biotech and pharmaceutical companies, with a visual timeline of past and upcoming events for each drug.
Insider Trading History View the most recent five years of insider trading activity and recent institutional buying and selling activity for any stock.
Key Financial Metrics View key financial metrics and technical indicators for any stock.
News and Social Media Feed View real-time news stories and social media postings from StockTwits for any publicly traded company.
Stock Charts View a real-time stock chart for any publicly traded company.

Proprietary Research Reports

Top Insider Buying
Top Insider Selling
Brokerage Performance Rankings
Analyst Performance Rankings
Top-Ranked Stocks
Lowest-Ranked Stocks
Most Upgraded
Most Downgraded
Trader's Guide to Equities Research
Stock Picks from Top-Rated Analysts View recent "buy" and "strong buy" ratings from our top-ranked research firms.
Monthly Premium Reports

Subscription Benefits

Priority Newsletter Delivery
Premium Customer Support
Ad-Free Browsing on MarketBeat.com
Get Started
Sign Up Start Your 30-Day Free Trial

MarketBeat All Access is $249 per year with annual billing or $29 per month with monthly billing. Annual billing saves $99 compared to paying monthly. Every new subscription includes a 30-day free trial or a 30-day money-back guarantee.

Yes. MarketBeat offers a free tier that includes the Daily Ratings newsletter, a watchlist of up to 10 stocks, the stock comparison tool, analyst upgrades and downgrades, and top news headlines.

A paid plan, MarketBeat All Access, adds unlimited watchlists, stock screeners, real-time alerts, premium research reports, the Idea Engine, analyst and brokerage following, and priority newsletter delivery.

MarketBeat's free plan covers the essentials: a daily newsletter, a 10-stock watchlist, basic research tools, and top headlines.

MarketBeat All Access expands on those tools with unlimited watchlists, six stock and ETF screeners with 75+ technical filters, real-time email and SMS alerts, exclusive research reports, the Idea Engine, earnings call transcripts, and priority newsletter delivery at 8:50 AM and 4:30 PM ET. 

See the full feature comparison here.

MarketBeat All Access is built for investors who want to save time finding research, track more than 10 stocks, and receive faster access to market-moving information through real-time alerts and premium research tools. Subscribers use it to monitor analyst ratings changes, earnings activity, dividend announcements, insider and institutional trading trends, and stock-specific news from a single platform.

Every new subscription includes a 30-day free trial or a 30-day money-back guarantee, so you can test whether it fits your investing workflow before committing. Thousands of investors currently subscribe to this premium subscription.

MarketBeat is a financial media company founded in 2011 and headquartered in Sioux Falls, South Dakota. MarketBeat is accredited by the Better Business Bureau (BBB), independently verified by SafeSiteCertified and PrivacyVerified, and has been featured in Barron's, the Wall Street Journal, CNBC, MarketWatch, and Seeking Alpha. Millions of investors read MarketBeat's daily newsletters. 

New subscribers get 30 days of full MarketBeat All Access for free. A payment method is required to start the trial, but you can cancel anytime within the 30 days online with no questions asked — you won't be charged.

After 30 days, your chosen plan (annual at $249/year or monthly at $29/month) begins automatically unless you cancel first. Free trials are limited to one per customer every 12 months.

The 30-day money-back guarantee applies to subscribers who skip the trial and subscribe directly.

Yes. You can cancel MarketBeat All Access online anytime through your account. Canceling stops future billing immediately; you'll keep access until the end of your current paid period. Every new subscription includes either a 30-day free trial or a 30-day money-back guarantee, so you can cancel during the trial without being charged, or request a full refund within the first 30 days of a direct subscription — no questions asked.

MarketBeat All Access includes unlimited stock watchlists, real-time email and SMS alerts, six stock and ETF screeners with 75+ technical filters, 15+ exclusive stock lists, 12+ industry reports, the Idea Engine for weekly stock ideas, monthly premium research reports (10–20 pages each), media sentiment analysis, Excel/CSV data export, priority newsletter delivery at 8:50 AM and 4:30 PM ET, and ad-free browsing. The full feature list is in the comparison above.

The Idea Engine™ is a MarketBeat All Access feature that uses AI models, algorithmic factors, and technical indicators to identify stocks showing near-term momentum, sentiment shifts, or other notable trading signals. New Idea Engine picks are released at the start of each week and delivered via email and SMS alerts to All Access subscribers.

MarketBeat All Access is designed for retail investors who want deeper market research, real-time alerts, and access to institutional-quality market data in one place. Subscribers use it to follow analyst ratings, insider and institutional trading activity, earnings calls, dividend announcements, and stock-specific news from a single dashboard.

It's well-suited for long-term investors, dividend-focused investors, and active stock-pickers following more than 10 positions. MarketBeat is not a brokerage and does not execute trades; most subscribers pair it with their existing brokerage account.

MarketBeat specializes in aggregating institutional-grade data — analyst ratings from hundreds of brokerage firms, insider Form 4 filings, 13F institutional holdings, earnings calls, and dividend announcements — and making it searchable and filterable for individual investors. MarketBeat provides data and research tools rather than specific buy/sell recommendations, and focuses on depth in U.S., Canadian, and U.K. markets. The proprietary MarketRank™ score combines analyst opinion, short interest, dividend strength, news and social media sentiment, institutional ownership, and earnings and valuation into a single score for each covered stock.

MarketBeat covers thousands of publicly traded companies listed on major exchanges in the United States (NYSE, NASDAQ, OTCMKTS), Canada (TSX), and the United Kingdom (LSE). Coverage includes common stocks, ETFs, ADRs, and dividend-paying securities. 

MarketBeat All Access integrates with most major U.S. brokerages through Plaid, the secure financial-data service used across fintech platforms. Once linked, your holdings are automatically imported into your MarketBeat watchlist and kept in sync. Supported brokerages include Charles Schwab, Vanguard, E*TRADE, Robinhood, Interactive Brokers, and most other major firms. MarketBeat does not execute trades — you continue to buy and sell through your brokerage directly.

Yes. MarketBeat All Access subscribers can follow individual Wall Street analysts or specific brokerage firms and receive email and SMS alerts whenever they take action — including new coverage initiations, ratings upgrades, ratings downgrades, price target changes, and coverage terminations. This lets investors track the analysts and firms whose research they trust most, without needing to monitor multiple platforms. MarketBeat aggregates ratings from hundreds of brokerages and tracks the historical accuracy of analysts in its database, so users can identify and follow top-rated analysts based on past performance.

Better Business Bureau        VerifiedSeller.org        SafeSiteCertified        PrivacyVerified

© MarketBeat Media, LLC 2010-2026. All rights reserved.
345 N Reid Place, Suite 620, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2026 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.